Loperamide 2mg capsules

国家: 英国

语言: 英文

来源: MHRA (Medicines & Healthcare Products Regulatory Agency)

现在购买

资料单张 资料单张 (PIL)
24-04-2020
产品特点 产品特点 (SPC)
17-09-2019
公众评估报告 公众评估报告 (PAR)
20-04-2020

有效成分:

Loperamide hydrochloride

可用日期:

Viatris UK Healthcare Ltd

ATC代码:

A07DA03

INN(国际名称):

Loperamide hydrochloride

剂量:

2mg

药物剂型:

Oral capsule

给药途径:

Oral

类:

No Controlled Drug Status

处方类型:

Valid as a prescribable product

產品總結:

BNF: 01040200; GTIN: 5016695380018

产品特点

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Loritax 2mg Capsules
Loperamide 2mg Capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Loperamide hydrochloride 2mg per capsule
Excipients with known effect: Contains lactose 100mg per capsule.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Capsule
Size 4, green opaque cap and a mauve opaque body, hard gelatin
capsule.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Loperamide is indicated for the symptomatic treatment of acute
diarrhoea in adults and children aged
12 years and over.
Loperamide is also indicated for the symptomatic treatment of acute
episodes of diarrhoea associated
with Irritable Bowel Syndrome (IBS) in adults aged 18 years and over
following initial diagnosis by a
doctor.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Loperamide hydrochloride 2mg capsules are for oral administration. The
capsules should be taken
with liquid.
_Adults and children aged 12 years and over _
_ _
_Acute diarrhoea:_
Two capsules initially (4mg), followed by 1 capsule (2mg) after every
loose stool. The maximum
daily dose should not exceed 6 capsules (12 mg).
_Symptomatic treatment of acute episodes of diarrhoea associated with
irritable bowel syndrome in _
_adults aged 18 years and over _
Two capsules (4 mg) to be taken initially, followed by 1 capsule (2
mg) after every loose stool, or as
previously advised by your doctor. The maximum daily dose should not
exceed 6 capsules (12 mg).
_Elderly:_
No dose adjustment is required for the elderly.
_Renal impairment: _
No dose adjustment is required for patients with renal impairment.
_ _
_Hepatic impairment:_
Although no pharmacokinetic data are available in patients with
hepatic impairment, this medicine
should be used with caution in such patients because of reduced first
pass metabolism (see section
4.4).
Method of administration
Oral use.
4.3 CONTRAINDICATIONS
Loperamide hydrochloride 2mg capsule is contraindicated:
•
in patients with known hypersensitivity to loperamide hydr
                                
                                阅读完整的文件
                                
                            

搜索与此产品相关的警报